Efficacy News and Research

RSS
Synthetic lectins inhibit HIV from entering cells

Synthetic lectins inhibit HIV from entering cells

EMA CHMP adopts positive opinion for DIFICLIR to treat C. difficile infection

EMA CHMP adopts positive opinion for DIFICLIR to treat C. difficile infection

YM BioSciences total revenue decreases to $1.5 million for fiscal 2011

YM BioSciences total revenue decreases to $1.5 million for fiscal 2011

Soy protein reduces progression of atherosclerosis in women within 5 years of menopause

Soy protein reduces progression of atherosclerosis in women within 5 years of menopause

STAAR's new Visian ICL with CentraFLOW technology showcased at ESCRS congress

STAAR's new Visian ICL with CentraFLOW technology showcased at ESCRS congress

New microbicide may block AIDS virus from infecting cells

New microbicide may block AIDS virus from infecting cells

Shire announces update on approval status and availability of ProAmatine SOH drug

Shire announces update on approval status and availability of ProAmatine SOH drug

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

InSightec's ExAblate Neuro system may treat chronic brain disorders

InSightec's ExAblate Neuro system may treat chronic brain disorders

NEJM publishes Boehringer Ingelheim's BIBF 1120 phase II trial on IPF

NEJM publishes Boehringer Ingelheim's BIBF 1120 phase II trial on IPF

Peptide receptor radiolabeled therapy shows promise against neuroendocrine tumors

Peptide receptor radiolabeled therapy shows promise against neuroendocrine tumors

Combination of SRIs and cognitive behavior therapy reduces pediatric OCD symptoms

Combination of SRIs and cognitive behavior therapy reduces pediatric OCD symptoms

HRPR before PCI procedures linked to increased risk of ischemic event in ACS patients

HRPR before PCI procedures linked to increased risk of ischemic event in ACS patients

Positive data from InVivo's biomaterial scaffold implant preclinical study on acute SCI

Positive data from InVivo's biomaterial scaffold implant preclinical study on acute SCI

Clinical trial to evaluate TAU's stem cell technology for ALS

Clinical trial to evaluate TAU's stem cell technology for ALS

Enrollment commences in Boehringer Ingelheim's TOviTO Phase III combination trial for COPD

Enrollment commences in Boehringer Ingelheim's TOviTO Phase III combination trial for COPD

UNC's new nanoparticle shows potential for cancer chemotherapy

UNC's new nanoparticle shows potential for cancer chemotherapy

Antivirals from shark cartilage compound squalamine

Antivirals from shark cartilage compound squalamine

Positive results from Orexo's OX219 clinical study on opioid dependence

Positive results from Orexo's OX219 clinical study on opioid dependence

Matrix receives FDA's tentative approval for novel co-packaged version of HIV/AIDS therapy

Matrix receives FDA's tentative approval for novel co-packaged version of HIV/AIDS therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.